Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 26 Carcinoma, Hepatocellular 22 Small Cell Lung Carcinoma 17 Lung Neoplasms 14 Neoplasms 13 Breast Neoplasms 9 Colorectal Neoplasms 7 Carcinoma, Renal Cell 7 Squamous Cell Carcinoma of Head and Neck 6 Urinary Bladder Neoplasms 5 Triple Negative Breast Neoplasms 5 Prostatic Neoplasms 5 Neoplasm Metastasis 5 Melanoma 5 Carcinoma, Transitional Cell 5 Uterine Cervical Neoplasms 4 Stomach Neoplasms 4 Sarcoma 4 Glioblastoma 4 Solid Tumors 3 Sarcoma, Alveolar Soft Part 3 Ovarian Neoplasms 3 Liver Neoplasms 3 Extensive Stage Lung Small Cell Carcinoma 3 Endometrial Neoplasms 3 Carcinoma 3 Treatment-Refractory Solid Tumors 2 Small Cell Lung Cancer Extensive Stage 2 Pancreatic Neoplasms 2 Osteosarcoma 2

Interventions

atezolizumab 1 Sodium Chloride 1 Radiotherapy 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Locally Advanced Cervical Cancer × atezolizumab × 90 days × Clear all

NCT03612791 2026-04-03

ATEZOLACC

Gustave Roussy, Cancer Campus, Grand Paris

Phase 2 Completed

Locally Advanced Cervical Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡